# First Guaranty Bancshares, Inc.: overview

FGBI · Nasdaq · CIK 1408534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fgbi.md) · [Financials](/companies/fgbi/financials.md) · [Filings](/companies/fgbi/filings.md) · [Insiders](/companies/fgbi/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [4.7 d](/filings/0001408534-25-000092.md) | [18.7 d](/filings/0001408534-26-000021.md) | [5.2](/filings/0001408534-26-000047.md) | [(18.6) d](/filings/0001408534-26-000072.md) | [28.7 d](/filings/0001408534-25-000092.md) | [(25.3) d](/filings/0001408534-26-000021.md) | [50.4](/filings/0001408534-26-000047.md) | [(15.4) d](/filings/0001408534-26-000072.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [24.3](/filings/0001408534-23-000018.md) | [34.2](/filings/0001408534-24-000021.md) | [6.9](/filings/0001408534-25-000015.md) | [30.7](/filings/0001408534-26-000021.md) | [(10.0)](/filings/0001408534-26-000021.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fgbi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.3m | 423,799 |  | Added +389,753 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.9m | 283,913 |  | Added +18,203 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.6m | 160,326 |  | Added +82,179 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $876.5k | 87,044 |  | Unchanged |
| [CULLEN INVESTMENT GROUP, LTD.](/funds/797203.md) | 2026-06-30 | $626.4k | 62,209 |  | Added +58 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $483.1k | 47,977 |  | Added +24,300 |
| [Empowered Funds, LLC](/funds/1592828.md) | 2026-06-30 | $480.9k | 47,753 |  | Unchanged |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $478.6k | 47,531 |  | Added +25,700 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $456.6k | 45,341 |  | Added +7,451 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $403.9k | 40,114 |  | New +40,114 |

## Recent filings

[All 828 filings](/companies/fgbi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:32 ET | [8-K](/filings/0001408534-26-000078.md) | 8.01 Other events | 0001408534-26-000078 |
| 2026-09-10 | 16:30 ET | [8-K](/filings/0001408534-26-000074.md) | 8.01 Other events | 0001408534-26-000074 |
| 2026-08-14 | 12:24 ET | [10-Q](/filings/0001408534-26-000072.md) | Quarterly report, period 2026-06-30 | 0001408534-26-000072 |
| 2026-08-07 | 16:30 ET | [8-K](/filings/0001408534-26-000069.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001408534-26-000069 |
| 2026-08-06 | 16:30 ET | [8-K](/filings/0001408534-26-000064.md) | 7.01 Regulation FD disclosure | 0001408534-26-000064 |
| 2026-08-05 | 15:00 ET | [8-K](/filings/0001408534-26-000062.md) | 8.01 Other events | 0001408534-26-000062 |
| 2026-07-31 | 16:30 ET | [8-K](/filings/0001408534-26-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001408534-26-000059 |
| 2026-07-27 | 16:31 ET | [8-K](/filings/0001408534-26-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001408534-26-000057 |
| 2026-06-04 | 16:32 ET | [8-K](/filings/0001408534-26-000052.md) | 8.01 Other events | 0001408534-26-000052 |
| 2026-05-22 | 13:20 ET | [8-K](/filings/0001408534-26-000049.md) | 5.07 Shareholder vote results | 0001408534-26-000049 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001408534-26-000021.md), filed Mar 31, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1408534
- Tickers: FGBI, FGBIP
- Exchange: Nasdaq
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: LA
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:44 ET. No prices; not investment advice.
